Drax exametazime and Malaria - a phase IV clinical study of FDA data
We study 5,354 people who take Drax exametazime or have Malaria. No report of Malaria is found in people who take Drax exametazime.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Drax Exametazime?
Drax exametazime has active ingredients of technetium tc-99m exametazime kit.
What is Malaria?
Malaria (a parasitic disease due to mosquito bite) is found to be associated with 400 drugs and 303 conditions by eHealthMe.
Do you take Drax exametazime and have Malaria?Check whether Malaria is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Malaria and when was it recovered:
Expand to all the drugs that have ingredients of technetium tc-99m exametazime kit:
Alternative drugs to, pros and cons of Drax exametazime:
Malaria treatments and more:
- Malaria (5,354 reports)
COVID vaccines that are related to Malaria:
- Malaria in Moderna COVID Vaccine
- Malaria in Pfizer BioNTech Covid Vaccine
- Malaria in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Malaria:
All the conditions that are associated with Malaria:
How the study uses the data?
The study uses data from the FDA. It is based on technetium tc-99m exametazime kit (the active ingredients of Drax exametazime) and Drax exametazime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xalatan and Eloxatin drug interaction - 7 seconds ago
- Votrient and Vitamin D3 drug interaction - 18 seconds ago
- Methotrexate and Keratitis - 20 seconds ago
- Migranal and Skin Blushing/Flushing - 26 seconds ago
- Cellcept and Omacor drug interaction - 33 seconds ago
- Bumetanide and Actinic Keratosis - 41 seconds ago
- Paroxetine Hydrochloride and Dexilant drug interaction - 42 seconds ago
- Phenytoin Sodium and Dizziness - 42 seconds ago
- Chantix and Facial Palsy Aggravated - 46 seconds ago
- Artificial Menopause and Presbyopia - 52 seconds ago